Our findings suggest that complete deletion of PKM2 in mice leads to chronic pro‐inflammatory signaling, exacerbated inflammation, and sustained CD86+ macrophage activation after infarction, which correlates with worse patient outcomes (O'Rourke et al., 2019). The gene discussed is CD86; the disease is infarction.